Skip to content

Shanghai Fosun Pharmaceutical Group Co Ltd Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 27, 2026 results vs estimates

Shanghai Fosun Pharmaceutical Group Co Ltd · E.600196.SHG · China
Use symbol E.600196.SHG in our API & Excel add-in to retrieve this data ↓
23.01
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -50%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 24.53%

Shanghai Fosun Pharmaceutical Group Co Ltd Forecast

Shanghai Fosun Pharmaceutical Group Co Ltd short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 24.5% a year, a typical one-standard-deviation range is 22.22–23.80 over a week, 21.38–24.64 over a month and 17.37–28.65 over a year. (Signals as of 5 Nov 2026.)

Shanghai Fosun Pharmaceutical Group Co Ltd Price Chart

MacroFinance.ai

Shanghai Fosun Pharmaceutical Group Co Ltd Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Shanghai Fosun Pharmaceutical Group Co Ltd
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Shanghai Fosun Pharmaceutical Group Co Ltd
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Shanghai Fosun Pharmaceutical Group Co Ltd
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Shanghai Fosun Pharmaceutical Group Co Ltd
P/E
17.48x
Cheap vs own history
QoQ −5.8%
YoY −18.9%
now 17.482415.42 low22.74 high
ⓘP/E As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
P/S
1.44x
Cheap vs own history
QoQ −2.7%
YoY −19.7%
now 1.4381.27 low1.89 high
ⓘP/S As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
P/B
1.22x
Cheap vs own history
QoQ −5.4%
YoY −17.1%
now 1.22151.08 low1.55 high
ⓘP/B As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
EV/EBITDA
9.79x
Cheap vs own history
QoQ −8.0%
YoY −52.0%
now 9.78728.67 low21.2 high
ⓘEV/EBITDA As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
EV/Sales
1.49x
Cheap vs own history
QoQ +1.7%
YoY −37.6%
now 1.48831.32 low2.48 high
ⓘEV/Sales As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Earnings Yield
5.7%
Strong vs own history
QoQ +6.2%
YoY +23.4%
now 5.724.4 low6.48 high
ⓘEarnings Yield As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Dividend Yield
4.6%
Mid-range vs own history
QoQ —
YoY —
now 4.57234.57 low5.18 high
ⓘDividend Yield As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Market Cap
$61.4B
Lowest in 5 years
QoQ −2.3%
YoY −13.2%
now 61446.578854,210 low74,647 high
ⓘMarket Cap As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Shanghai Fosun Pharmaceutical Group Co Ltd
Net Debt
$2.1B
Low vs own history
QoQ −457.2%
YoY −90.8%
now 2149.9044-601.82 low23,475 high
ⓘNet Debt As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Net Debt / EBITDA
0.33x
Low vs own history
QoQ −422.2%
YoY −93.5%
now 0.3309-0.1 low5.07 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Current Ratio
0.98x
Mid-range vs own history
QoQ +8.5%
YoY +6.8%
now 0.97850.9 low0.98 high
ⓘCurrent Ratio As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Quick Ratio
0.81x
Mid-range vs own history
QoQ +8.2%
YoY +12.1%
now 0.80860.72 low0.81 high
ⓘQuick Ratio As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Interest Coverage
4.55x
Strong vs own history
QoQ +104.4%
YoY +38.7%
now 4.55372.23 low4.55 high
ⓘInterest Coverage As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Debt / Equity
0.31x
Low vs own history
QoQ +15.0%
YoY −60.1%
now 0.30710.26 low0.77 high
ⓘDebt / Equity As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Piotroski F-Score
6
Mid-range vs own history
QoQ +20.0%
YoY +20.0%
now 65 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Shanghai Fosun Pharmaceutical Group Co Ltd
Altman Z-Score
1.42
Mid-range vs own history
QoQ +7.9%
YoY −5.7%
now 1.41981.26 low1.55 high
ⓘAltman Z-Score As of 22 Nov 2026.See Shanghai Fosun Pharmaceutical Group Co Ltd returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  14 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  14 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Shanghai Fosun Pharmaceutical Group Co Ltd, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Shanghai Fosun Pharmaceutical Group Co Ltd fundamentals: income statement, balance sheet & cash flow

Shanghai Fosun Pharmaceutical Group Co Ltd reported revenue of 41.50bn CNY and net income of 3.37bn CNY in FY2025, the year ended 31 December 2025 — revenue up 1.1% and net income up 21.7% on the prior year. Free cash flow was 1.56bn CNY. These figures are as reported in the filings, not restated: 31 fiscal years and 99 quarters of history, back to December 1995.

Revenue (FY2025)
41.50bn CNY
+1.1%
Net income
3.37bn CNY
+21.7%
Gross margin
46.06%
Free cash flow
1.56bn CNY
+2,230.9%
Net debt
27.34bn CNY
Shanghai Fosun Pharmaceutical Group Co Ltd income statement, annual, as reported · CNY billions unless stated
CNY billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue41.5041.0741.4043.9539.01
Cost of revenue22.3921.4321.7223.2620.29
Gross profit19.1219.6419.6820.7018.72
Research & development3.563.684.374.303.99
Selling, general & admin.—11.7212.0111.738.42
Operating income2.524.253.314.666.30
EBITDA6.105.513.885.544.18
Interest expense1.301.471.360.990.85
Pre-tax income5.114.173.264.576.04
Income tax0.860.660.370.631.07
Net income3.372.772.393.734.73

Download Shanghai Fosun Pharmaceutical Group Co Ltd fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.600196.SHG&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 31 fiscal years and 99 quarters, the filing vintages behind each number and API access.
Create free account

Figures in CNY, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Shanghai Fosun Pharmaceutical Group Co Ltd

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Shanghai Fosun Pharmaceutical Group Co Ltd Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Shanghai Fosun Pharmaceutical Group Co Ltd; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Shanghai Fosun Pharmaceutical Group Co Ltd’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Shanghai Fosun Pharmaceutical Group Co Ltd behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Shanghai Fosun Pharmaceutical Group Co Ltd (China)

Shanghai Fosun Pharmaceutical Group Co Ltd is a listed security in China. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Shanghai Fosun Pharmaceutical Group Co Ltd?
Shanghai Fosun Pharmaceutical Group Co Ltd is a listed security in China. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Shanghai Fosun Pharmaceutical Group Co Ltd price?
The latest close is 23.01 (5 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Shanghai Fosun Pharmaceutical Group Co Ltd in an uptrend?
As of 5 Nov 2026, short-term momentum is negative (1 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Shanghai Fosun Pharmaceutical Group Co Ltd?
20-day realised volatility is 24.5% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 7.1% over a month and 3.5% over a week.
What factors affect Shanghai Fosun Pharmaceutical Group Co Ltd?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Shanghai Fosun Pharmaceutical Group Co Ltd, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Shanghai Fosun Pharmaceutical Group Co Ltd?
28 backtested tactical asset allocation strategies trade Shanghai Fosun Pharmaceutical Group Co Ltd through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Shanghai Fosun Pharmaceutical Group Co Ltd returns analysed?
The Statistical Distribution of Returns section shows the distribution of Shanghai Fosun Pharmaceutical Group Co Ltd daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Shanghai Fosun Pharmaceutical Group Co Ltd historical data?
In the Free historical data section of this page: the last 10 years of Shanghai Fosun Pharmaceutical Group Co Ltd daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Shanghai Fosun Pharmaceutical Group Co Ltd historical data (last 10 years)

Browse or instantly download the last 10 years of Shanghai Fosun Pharmaceutical Group Co Ltd daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.600196.SHG&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2020.3
2026-11-1920.71
2026-11-1820.82
2026-11-1720.81
2026-11-1622.33
2026-11-1322.53
2026-11-1222.81
2026-11-1122.92
2026-11-1023.4
2026-11-0923.11
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.